NEWGEN - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.7
| Stock Code | NEWGEN | Market Cap | 6,235 Cr. | Current Price | 438 ₹ | High / Low | 1,336 ₹ |
| Stock P/E | 19.6 | Book Value | 115 ₹ | Dividend Yield | 1.37 % | ROCE | 26.2 % |
| ROE | 20.8 % | Face Value | 10.0 ₹ | DMA 50 | 486 ₹ | DMA 200 | 686 ₹ |
| Chg in FII Hold | -2.86 % | Chg in DII Hold | -0.83 % | PAT Qtr | 110 Cr. | PAT Prev Qtr | 79.8 Cr. |
| RSI | 38.4 | MACD | -6.92 | Volume | 7,32,904 | Avg Vol 1Wk | 6,55,211 |
| Low price | 401 ₹ | High price | 1,336 ₹ | PEG Ratio | 0.82 | Debt to equity | 0.02 |
| 52w Index | 3.94 % | Qtr Profit Var | 8.13 % | EPS | 20.0 ₹ | Industry PE | 20.7 |
📊 Financials: The company shows solid profitability with ROE at 20.8% and ROCE at 26.2%, reflecting efficient capital usage. Debt-to-equity is very low at 0.02, indicating a nearly debt-free balance sheet. Quarterly PAT rose from ₹79.8 Cr. to ₹110 Cr., an 8.13% variation, highlighting stable earnings growth. EPS of ₹20.0 supports consistent cash flow generation.
💹 Valuation: Current P/E of 19.6 is slightly below the industry average of 20.7, suggesting fair valuation. The PEG ratio of 0.82 indicates attractive growth prospects relative to price. Book value of ₹115 against a market price of ₹438 implies a stretched P/B ratio. Intrinsic value appears close to current levels, offering limited upside.
🏭 Business Model: The company operates in enterprise software solutions, benefiting from demand in digital transformation, automation, and workflow management. Competitive advantage lies in niche offerings, innovation, and strong client base, though valuations remain sensitive to growth consistency.
📈 Entry Zone: A favorable entry would be closer to ₹420–430, near the recent low of ₹401. Current price of ₹438 is slightly above fair value, so accumulation on dips is recommended.
⏳ Long-Term Holding: Strong fundamentals, low debt, and consistent profitability support long-term holding. However, weak momentum indicators suggest cautious accumulation rather than aggressive buying.
Positive
- ✅ Strong ROE (20.8%) and ROCE (26.2%)
- ✅ Debt-free balance sheet (Debt-to-equity 0.02)
- ✅ EPS of ₹20.0 supports cash flow generation
- ✅ Dividend yield of 1.37% adds shareholder value
Limitation
- ⚠️ Stretched P/B ratio (Price ₹438 vs. Book Value ₹115)
- ⚠️ RSI at 38.4 indicates weak momentum
- ⚠️ MACD at -6.92 suggests bearish technical sentiment
Company Negative News
- 📉 Decline in FII holding (-2.86%) shows reduced foreign investor confidence
- 📉 Decline in DII holding (-0.83%) shows reduced domestic institutional support
Company Positive News
- 📈 PAT growth from ₹79.8 Cr. to ₹110 Cr. shows operational resilience
- 📈 Dividend yield of 1.37% provides shareholder returns
Industry
- 💻 Enterprise software sector benefits from digital transformation demand
- 📊 Industry P/E at 20.7 suggests peers are valued slightly higher
- 🌍 Growth opportunities in automation, workflow management, and cloud adoption
Conclusion
Overall, the company is financially strong with solid return ratios, low debt, and consistent earnings growth. However, weak momentum indicators and stretched P/B ratio limit upside potential. Best strategy is cautious accumulation near ₹420–430 for long-term holding, while avoiding aggressive buying at current levels.
Would you like me to extend this with a peer comparison against other enterprise software companies, or a technical analysis view to highlight support/resistance and momentum indicators?